{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:01:50Z","timestamp":1792184510072,"version":"4.4.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Following the COVID-19 virus epidemic, extensive, coordinated international research has led to the rapid development of effective vaccines.\u00a0Although\u00a0vaccines are now considered the best way to achieve collective safety and control mortality, due to the critical situation, these vaccines have been issued the emergency use licenses and\u00a0some of their\u00a0potential\u00a0subsequence side effects have been overlooked. At the same time, there are many reports of side effects after getting a COVID-19 vaccine. According to these reports, vaccination can have an adverse event, especially on nervous system. The most important and common complications\u00a0are cerebrovascular\u00a0disorders including cerebral venous sinus thrombosis, transient ischemic attack, intracerebral hemorrhage, ischemic stroke, and demyelinating\u00a0disorders including transverse myelitis, first manifestation of MS, and neuromyelitis optica. These effects are often acute and transient, but they can be severe and even fatal in a few cases. Herein, we have provided a comprehensive review of documents reporting neurological side effects of COVID-19 vaccines in international databases from 2020 to 2022 and discussed neurological disorders possibly caused by vaccination.<\/jats:p>","DOI":"10.1186\/s40001-023-00992-0","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T04:03:17Z","timestamp":1677297797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["A review of neurological side effects of COVID-19 vaccination"],"prefix":"10.1186","volume":"28","author":[{"given":"Roya","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayere","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"992_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05662-9","author":"RK Garg","year":"2021","unstructured":"Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2021. https:\/\/doi.org\/10.1007\/s10072-021-05662-9.","journal-title":"Neurol Sci"},{"key":"992_CR2","unstructured":"who.int. https:\/\/covid19.who.int\/mapFilter=deaths. Accessed 13 Novr 2022"},{"key":"992_CR3","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.csbj.2021.04.061","volume":"19","author":"A Nagy","year":"2021","unstructured":"Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. 2021;19:2508\u201317.","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"992_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-014-0488-1","volume":"16","author":"G Abraham","year":"2014","unstructured":"Abraham G, Bhalala OG, de Bakker PI, Ripatti S, Inouye M. Towards a molecular systems model of coronary artery disease. Curr Cardiol Rep. 2014;16(6):1\u201310.","journal-title":"Curr Cardiol Rep"},{"issue":"12","key":"992_CR5","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1002\/jmv.27214","volume":"93","author":"QA Al Khames Aga","year":"2021","unstructured":"Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, Shaban D, Al Khames Aga LA, Agha MY, Traqchi M. Safety of COVID-19 vaccines. J Med Virol. 2021;93(12):6588\u201394.","journal-title":"J Med Virol"},{"issue":"3","key":"992_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","volume":"13","author":"D Karussis","year":"2014","unstructured":"Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215\u201324.","journal-title":"Autoimmun Rev"},{"key":"992_CR7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21376","author":"S Dutta","year":"2022","unstructured":"Dutta S, Kaur R, Charan J, Bhardwaj P, Ambwani SR, Babu S, Goyal JP, Haque M. Analysis of neurological adverse events reported in VigiBase from COVID-19 vaccines. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.21376.","journal-title":"Cureus"},{"issue":"1","key":"992_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ane.13550","volume":"145","author":"J Finsterer","year":"2022","unstructured":"Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022;145(1):5\u20139.","journal-title":"Acta Neurol Scand"},{"key":"992_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577765","volume":"362","author":"II Ismail","year":"2022","unstructured":"Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol. 2022;362: 577765.","journal-title":"J Neuroimmunol"},{"key":"992_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/NDT.S343438","volume":"18","author":"SA Assiri","year":"2022","unstructured":"Assiri SA, Althaqafi RM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A. Post COVID-19 vaccination-associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"992_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.34172\/ipp.2021.31","volume":"7","author":"N Ghiasi","year":"2021","unstructured":"Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, Jahantigh HR. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathologia Persa. 2021;7(2):31.","journal-title":"Immunopathologia Persa"},{"key":"992_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","volume":"111","author":"BQ Saeed","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021;111:219\u201326.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"992_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","volume":"21","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial. Lancet Infect Dis. 2021;21(2):181\u201392.","journal-title":"Lancet Infect Dis"},{"key":"992_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17514-3","author":"I Kadyrova","year":"2022","unstructured":"Kadyrova I, Yegorov S, Negmetzhanov B, Kolesnikova Y, Kolesnichenko S, Korshukov I, Baiken Y, Matkarimov B, Miller MS, Hortelano GH. Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study. medRxiv. 2022. https:\/\/doi.org\/10.1038\/s41598-022-17514-3.","journal-title":"medRxiv"},{"issue":"3","key":"992_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13760-021-01608-2","volume":"122","author":"L Cao","year":"2021","unstructured":"Cao L, Ren L. Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report. Acta Neurol Belg. 2021;122(3):793\u20135.","journal-title":"Acta Neurol Belg"},{"issue":"7\u201308","key":"992_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.18071\/isz.74.0273","volume":"74","author":"N\u015e Erdem","year":"2021","unstructured":"Erdem N\u015e, Demirci S, \u00d6zel T, Mamadova K, Karaali K, \u00c7elik HT, Uslu FI, \u00d6zkaynak SS. Acute transverse myelitis after inactivated COVID-19 vaccine. Ideggyogyaszati Szemle. 2021;74(7\u201308):273\u20136.","journal-title":"Ideggyogyaszati Szemle"},{"issue":"3","key":"992_CR17","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00415-021-10785-2","volume":"269","author":"E Khan","year":"2021","unstructured":"Khan E, Shrestha AK, Colantonio MA, Liberio RN, Sriwastava S. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. J Neurol. 2021;269(3):1121\u201332.","journal-title":"J Neurol"},{"key":"992_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab069","author":"HS Malhotra","year":"2021","unstructured":"Malhotra HS, Gupta P, Prabhu V, Garg RK, Dandu H, Agarwal V. COVID-19 vaccination-associated myelitis. QJM: An Int J Med. 2021. https:\/\/doi.org\/10.1093\/qjmed\/hcab069.","journal-title":"QJM: An Int J Med"},{"key":"992_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.clinimag.2021.08.021","volume":"80","author":"DG Corr\u00eaa","year":"2021","unstructured":"Corr\u00eaa DG, Ca\u00f1ete LAQ, Dos Santos GAC, de Oliveira RV, Brand\u00e3o CO, da Cruz Jr LCH. Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: Cause or coincidence? Clin Imaging. 2021;80:348\u201352.","journal-title":"Clin Imaging"},{"issue":"4","key":"992_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s13760-021-01699-x","volume":"121","author":"G Ozgen Kenangil","year":"2021","unstructured":"Ozgen Kenangil G, Ari BC, Guler C, Demir MK. Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine. Acta Neurol Belg. 2021;121(4):1089\u201391.","journal-title":"Acta Neurol Belg"},{"issue":"9","key":"992_CR21","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1007\/s10072-021-05427-4","volume":"42","author":"S Chen","year":"2021","unstructured":"Chen S, Fan X-R, He S, Zhang J-W, Li S-J. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci. 2021;42(9):3537\u20139.","journal-title":"Neurol Sci"},{"key":"992_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01775-2","author":"M Seyed Ahadi","year":"2021","unstructured":"Seyed Ahadi M, Ghadiri F, Naser Moghadasi A. Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report. Acta Neurol Belg. 2021. https:\/\/doi.org\/10.1007\/s13760-021-01775-2.","journal-title":"Acta Neurol Belg"},{"issue":"7","key":"992_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243829","volume":"14","author":"A Burrows","year":"2021","unstructured":"Burrows A, Bartholomew T, Rudd J, Walker D. Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses. BMJ Case Reports CP. 2021;14(7): e243829.","journal-title":"BMJ Case Reports CP"},{"issue":"10","key":"992_CR24","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1007\/s10072-021-05504-8","volume":"42","author":"T Ercoli","year":"2021","unstructured":"Ercoli T, Lutzoni L, Orofino G, Muroni A, Defazio G. Functional neurological disorder after COVID-19 vaccination. Neurol Sci. 2021;42(10):3989\u201390.","journal-title":"Neurol Sci"},{"issue":"9","key":"992_CR25","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.4103\/ijo.IJO_1658_21","volume":"69","author":"S Ish","year":"2021","unstructured":"Ish S, Ish P. Facial nerve palsy after COVID-19 vaccination\u2013A rare association or a coincidence. Indian J Ophthalmol. 2021;69(9):2550.","journal-title":"Indian J Ophthalmol"},{"issue":"4\u20135","key":"992_CR26","first-page":"366","volume":"42","author":"E Ekizoglu","year":"2021","unstructured":"Ekizoglu E, Gezegen H, Yal\u0131nay Dikmen P, Orhan EK, Erta\u015f M, Baykan B (2021) The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic. Cephalalgia. 42(4\u20135):366\u201375.","journal-title":"Cephalalgia."},{"issue":"4","key":"992_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.26172","volume":"90","author":"JB Schulz","year":"2021","unstructured":"Schulz JB, Berlit P, Diener HC, Gerloff C, Greinacher A, Klein C, Petzold GC, Piccininni M, Poli S, R\u00f6hrig R. COVID-19 vaccine-associated cerebral venous thrombosis in Germany. Ann Neurol. 2021;90(4):627\u201339.","journal-title":"Ann Neurol"},{"issue":"1","key":"992_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005211","volume":"50","author":"T Iba","year":"2022","unstructured":"Iba T, Levy JH, Warkentin TE. Recognizing vaccine-induced immune thrombotic thrombocytopenia. Crit Care Med. 2022;50(1): e80.","journal-title":"Crit Care Med"},{"key":"992_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102662","volume":"121","author":"D McGonagle","year":"2021","unstructured":"McGonagle D, De Marco G, Bridgewood C. Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection. J Autoimmun. 2021;121: 102662.","journal-title":"J Autoimmun"},{"issue":"8","key":"992_CR30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1056\/NEJMoa2107051","volume":"385","author":"A Bourguignon","year":"2021","unstructured":"Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZA, Shroff A, Lessard M-C, Blais N. Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia. New Engl J Med. 2021;385(8):720\u20138.","journal-title":"New Engl J Med"},{"issue":"4","key":"992_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.annemergmed.2021.04.035","volume":"78","author":"RT Clark","year":"2021","unstructured":"Clark RT, Johnson L, Billotti J, Foulds G, Ketels T, Heard K, Hynes EC. Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26. COV2.S vaccination. Ann Emergency Med. 2021;78(4):511\u20134.","journal-title":"Ann Emergency Med"},{"issue":"4","key":"992_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/jpm11040285","volume":"11","author":"V D\u2019agostino","year":"2021","unstructured":"D\u2019agostino V, Caranci F, Negro A, Piscitelli V, Tuccillo B, Fasano F, Sirabella G, Marano I, Granata V, Grassi R. A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J Personal Med. 2021;11(4):285.","journal-title":"J Personal Med"},{"key":"992_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2021.04.001","volume":"202","author":"M Franchini","year":"2021","unstructured":"Franchini M, Testa S, Pezzo M, Glingani C, Caruso B, Terenziani I, Pognani C, Bellometti SA, Castelli G. Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination. Thromb Res. 2021;202:182\u20133.","journal-title":"Thromb Res"},{"issue":"1","key":"992_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01324-5","volume":"22","author":"D Garc\u00eda-Azor\u00edn","year":"2021","unstructured":"Garc\u00eda-Azor\u00edn D, Do TP, Gantenbein AR, Hansen JM, Souza MNP, Obermann M, Pohl H, Schankin CJ, Schytz HW, Sinclair A. Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain. 2021;22(1):1\u20135.","journal-title":"J Headache Pain"},{"issue":"8","key":"992_CR35","doi-asserted-by":"publisher","first-page":"E301","DOI":"10.1002\/ajh.26237","volume":"96","author":"G George","year":"2021","unstructured":"George G, Friedman KD, Curtis BR, Lind SE. Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26. COV2. S vaccination. Am J Hematol. 2021;96(8):E301\u20133.","journal-title":"Am J Hematol"},{"key":"992_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17619","author":"S Ramdeny","year":"2021","unstructured":"Ramdeny S, Lang A, Al-Izzi S, Hung A, Anwar I, Kumar P. Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT). Br J Haematol. 2021. https:\/\/doi.org\/10.1111\/bjh.17619.","journal-title":"Br J Haematol"},{"issue":"23","key":"992_CR37","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. New Engl J Med. 2021;384(23):2202\u201311.","journal-title":"New Engl J Med"},{"key":"992_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117607","volume":"428","author":"M Sharifian-Dorche","year":"2021","unstructured":"Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. 2021;428: 117607.","journal-title":"J Neurol Sci"},{"issue":"9","key":"992_CR39","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3390\/vaccines9091008","volume":"9","author":"J-J Gao","year":"2021","unstructured":"Gao J-J, Tseng H-P, Lin C-L, Shiu J-S, Lee M-H, Liu C-H. Acute transverse myelitis following COVID-19 vaccination. Vaccines. 2021;9(9):1008.","journal-title":"Vaccines"},{"issue":"5","key":"992_CR40","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0470","volume":"21","author":"AA Notghi","year":"2021","unstructured":"Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Northfield Il). 2021;21(5): e535.","journal-title":"Clin Med (Northfield Il)"},{"key":"992_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577606","volume":"358","author":"C Pagenkopf","year":"2021","unstructured":"Pagenkopf C, S\u00fcdmeyer M. A case of longitudinally extensive transverse myelitis following vaccination against Covid-19. J Neuroimmunol. 2021;358: 577606.","journal-title":"J Neuroimmunol"},{"key":"992_CR42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16624","author":"N Tahir","year":"2021","unstructured":"Tahir N, Koorapati G, Prasad S, Jeelani HM, Sherchan R, Shrestha J, Shayuk M. SARS-CoV-2 vaccination-induced transverse myelitis. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.16624.","journal-title":"Cureus"},{"key":"992_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577686","volume":"359","author":"E Vegezzi","year":"2021","unstructured":"Vegezzi E, Ravaglia S, Buongarzone G, Bini P, Diamanti L, Gastaldi M, Prunetti P, Rognone E, Marchioni E. Acute myelitis and ChAdOx1 nCoV-19 vaccine: casual or causal association? J Neuroimmunol. 2021;359: 577686.","journal-title":"J Neuroimmunol"},{"issue":"10269","key":"992_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021;397(10269):99\u2013111.","journal-title":"The Lancet"},{"issue":"2","key":"992_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.26144","volume":"90","author":"CM Allen","year":"2021","unstructured":"Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, Evans JR. Guillain-Barr\u00e9 syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. 2021;90(2):315\u20138.","journal-title":"Ann Neurol"},{"key":"992_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327027","author":"GB Bonifacio","year":"2021","unstructured":"Bonifacio GB, Patel D, Cook S, Purcaru E, Couzins M, Domjan J, Ryan S, Alareed A, Tuohy O, Slaght S. Bilateral facial weakness with paraesthesia variant of Guillain-Barr\u00e9 syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg Psychiatry. 2021. https:\/\/doi.org\/10.1136\/jnnp-2021-327027.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"992_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243629","volume":"14","author":"T Hasan","year":"2021","unstructured":"Hasan T, Khan M, Khan F, Hamza G. Case of Guillain-Barr\u00e9 syndrome following COVID-19 vaccine. BMJ Case Reports CP. 2021;14(6): e243629.","journal-title":"BMJ Case Reports CP"},{"key":"992_CR48","doi-asserted-by":"publisher","DOI":"10.9734\/ijmpcr\/2021\/v14i130124","author":"S Kohli","year":"2021","unstructured":"Kohli S, Varshney M, Mangla S, Jaiswal B, Chhabra PH. Guillain-Barr\u00e9 syndrome after COVID-19 vaccine: should we assume a causal Link? Int J Med Pharm Case Rep: 20-24. 2021. https:\/\/doi.org\/10.9734\/ijmpcr\/2021\/v14i130124.","journal-title":"Int J Med Pharm Case Rep: 20-24"},{"key":"992_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s12024-021-00440-7","author":"F Permezel","year":"2021","unstructured":"Permezel F, Borojevic B, Lau S, de Boer HH. Acute disseminated encephalomyelitis (ADEM) following recent Oxford\/AstraZeneca COVID-19 vaccination. Forensic Sci Med Pathol. 2021. https:\/\/doi.org\/10.1007\/s12024-021-00440-7.","journal-title":"Forensic Sci Med Pathol"},{"key":"992_CR50","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.21.0312","author":"TH Bj\u00f8rnstad-Tuveng","year":"2021","unstructured":"Bj\u00f8rnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskrift for Den norske legeforening. 2021. https:\/\/doi.org\/10.4045\/tidsskr.21.0312.","journal-title":"Tidsskrift for Den norske legeforening"},{"key":"992_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577661","volume":"358","author":"L Baldelli","year":"2021","unstructured":"Baldelli L, Amore G, Montini A, Panzera I, Rossi S, Cortelli P, Guarino M, Rinaldi R, D\u2019Angelo R. Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine. J Neuroimmunol. 2021;358: 577661.","journal-title":"J Neuroimmunol"},{"key":"992_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2021.05.002","author":"J Antonio Crespo Burillo","year":"2021","unstructured":"Antonio Crespo Burillo J, Mart\u00ednez CL, Arguedas CG, Pueyo FJM. Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine. Neurologia (Barc, Ed impr). 2021. https:\/\/doi.org\/10.1016\/j.nrleng.2021.05.002.","journal-title":"Neurologia (Barc, Ed impr)"},{"key":"992_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17555","author":"M Alpalh\u00e3o","year":"2021","unstructured":"Alpalh\u00e3o M, Filipe P. Herpes Zoster following SARS-CoV-2 vaccination\u2013a series of four cases. J Eur Acad Dermatol Venereol. 2021. https:\/\/doi.org\/10.1111\/jdv.17555.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"992_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab210","author":"P-T Tseng","year":"2021","unstructured":"Tseng P-T, Chen T-Y, Sun Y-S, Chen Y-W, Chen J-J. The reversible tinnitus and cochleopathy followed first-dose AstraZeneca COVID-19 vaccination. QJM An Int J Med. 2021. https:\/\/doi.org\/10.1093\/qjmed\/hcab210.","journal-title":"QJM An Int J Med"},{"key":"992_CR55","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e3286","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA, Scorza CA. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients. Clinics. 2021. https:\/\/doi.org\/10.6061\/clinics\/2021\/e3286.","journal-title":"Clinics"},{"key":"992_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106887","volume":"208","author":"A Introna","year":"2021","unstructured":"Introna A, Caputo F, Santoro C, Guerra T, Ucci M, Mezzapesa DM, Trojano M. Guillain-Barr\u00e9 syndrome after AstraZeneca COVID-19-vaccination: a causal or casual association? Clin Neurol Neurosurg. 2021;208: 106887.","journal-title":"Clin Neurol Neurosurg"},{"key":"992_CR57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16612","author":"E Jain","year":"2021","unstructured":"Jain E, Pandav K, Regmi P, Michel G, Altshuler I. Facial diplegia: a rare, atypical variant of Guillain-Barr\u00e9 syndrome and Ad26. COV2. S Vaccine. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.16612.","journal-title":"Cureus"},{"issue":"22","key":"992_CR58","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1212\/WNL.0000000000011881","volume":"96","author":"AMM Loza","year":"2021","unstructured":"Loza AMM, Holroyd KB, Johnson SA, Pilgrim DM, Amato AA. Guillain-Barr\u00e9 syndrome in the placebo and active arms of a COVID-19 vaccine clinical trial: temporal associations do not imply causality. Neurology. 2021;96(22):1052\u20134.","journal-title":"Neurology"},{"issue":"7","key":"992_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243975","volume":"14","author":"B Malik","year":"2021","unstructured":"Malik B, Kalantary A, Rikabi K, Kunadi A. Pulmonary embolism, transient ischaemic attack and thrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Reports CP. 2021;14(7): e243975.","journal-title":"BMJ Case Reports CP"},{"issue":"10","key":"992_CR60","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1080\/21645515.2021.1928463","volume":"17","author":"M Etemadifar","year":"2021","unstructured":"Etemadifar M, Sigari AA, Sedaghat N, Salari M, Nouri H. Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin Immunother. 2021;17(10):3481\u20133.","journal-title":"Hum Vaccin Immunother"},{"key":"992_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab335","author":"H-T Fan","year":"2022","unstructured":"Fan H-T, Lin Y-Y, Chiang W-F, Lin C-Y, Chen M-H, Wu K-A, Chan J-S, Kao Y-H, Shyu H-Y, Hsiao P-J. COVID-19 vaccine-induced encephalitis and status epilepticus. QJM: An Int J Med. 2022. https:\/\/doi.org\/10.1093\/qjmed\/hcab335.","journal-title":"QJM: An Int J Med"},{"key":"992_CR62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3389\/fimmu.2021.653786","volume":"12","author":"GC Rom\u00e1n","year":"2021","unstructured":"Rom\u00e1n GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute transverse myelitis (ATM): clinical review of 43 patients with COVID-19-associated ATM and 3 post-vaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front Immunol. 2021;12:879.","journal-title":"Front Immunol"},{"issue":"4","key":"992_CR63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","volume":"21","author":"A Ozonoff","year":"2021","unstructured":"Ozonoff A, Nanishi E, Levy O. Bell\u2019s palsy and SARS-CoV-2 vaccines. Lancet Infect Dis. 2021;21(4):450\u20132.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"992_CR64","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mus.27251","volume":"64","author":"W Waheed","year":"2021","unstructured":"Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve. 2021;64(1):E1.","journal-title":"Muscle Nerve"},{"key":"992_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1786","author":"O Dyer","year":"2021","unstructured":"Dyer O. Covid-19: Regulators warn that rare Guillain-Barr\u00e9 cases may link to J&J and AstraZeneca vaccines. Br Med J Publ Gr. 2021. https:\/\/doi.org\/10.1136\/bmj.n1786.","journal-title":"Br Med J Publ Gr"},{"issue":"3","key":"992_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/RMR.0000000000000287","volume":"30","author":"G Keir","year":"2021","unstructured":"Keir G, Maria NI, Kirsch CF. Unique imaging findings of neurologic phantosmia following Pfizer-BioNtech COVID-19 vaccination: a case report. Top Magn Reson Imaging. 2021;30(3):133\u20137.","journal-title":"Top Magn Reson Imaging"},{"issue":"9","key":"992_CR67","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00011-021-01476-9","volume":"70","author":"LS Santovito","year":"2021","unstructured":"Santovito LS, Pinna G. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report. Inflammation Res. 2021;70(9):931\u20133.","journal-title":"Inflammation Res"},{"key":"992_CR68","doi-asserted-by":"publisher","DOI":"10.1080\/14992027.2021.1931969","author":"D Parrino","year":"2021","unstructured":"Parrino D, Frosolini A, Gallo C, De Siati RD, Spinato G, de Filippis C. Tinnitus following COVID-19 vaccination: report of three cases. Int J Audiol. 2021. https:\/\/doi.org\/10.1080\/14992027.2021.1931969.","journal-title":"Int J Audiol"},{"issue":"9","key":"992_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000003275","volume":"42","author":"H Wichova","year":"2021","unstructured":"Wichova H, Miller ME, Derebery MJ. Otologic manifestations after COVID-19 vaccination: the house ear clinic experience. Otol Neurotol. 2021;42(9): e1213.","journal-title":"Otol Neurotol"},{"key":"992_CR70","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/IMCRJ.S315103","volume":"14","author":"L \u017dori\u0107","year":"2021","unstructured":"\u017dori\u0107 L, Rajovi\u0107-Mrki\u0107 I, \u010colak E, Miri\u0107 D, Kisi\u0107 B. Optic neuritis in a patient with seropositive myelin oligodendrocyte glycoprotein antibody during the post-COVID-19 period. Int Med Case Rep J. 2021;14:349.","journal-title":"Int Med Case Rep J"},{"key":"992_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2021-141022","author":"CJ Woo","year":"2022","unstructured":"Woo CJ, Chou OHI, Cheung BMY. Ramsay Hunt syndrome following COVID-19 vaccination. Postgrad Med J. 2022. https:\/\/doi.org\/10.1136\/postgradmedj-2021-141022.","journal-title":"Postgrad Med J"},{"issue":"1","key":"992_CR72","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","volume":"85","author":"DE McMahon","year":"2021","unstructured":"McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46\u201355.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"992_CR73","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/braincomms\/fcab169","volume":"3","author":"CH G\u00f6bel","year":"2021","unstructured":"G\u00f6bel CH, Heinze A, Karstedt S, Morscheck M, Tashiro L, Cirkel A, Hamid Q, Halwani R, Temsah M-H, Ziemann M. Clinical characteristics of headache after vaccination against COVID-19 (coronavirus SARS-CoV-2) with the BNT162b2 mRNA vaccine: a multicentre observational cohort study. Brain Commun. 2021;3(3):169.","journal-title":"Brain Commun"},{"issue":"10267","key":"992_CR74","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","volume":"396","author":"MN Ramasamy","year":"2020","unstructured":"Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, Voysey M, Aley PK, Angus B, Babbage G. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial. The Lancet. 2020;396(10267):1979\u201393.","journal-title":"The Lancet"},{"issue":"1","key":"992_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","volume":"269","author":"J Havla","year":"2022","unstructured":"Havla J, Schultz Y, Zimmermann H, Hohlfeld R, Danek A, K\u00fcmpfel T. First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine. J Neurol. 2022;269(1):55\u20138.","journal-title":"J Neurol"},{"key":"992_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10780-7","author":"M Khayat-Khoei","year":"2021","unstructured":"Khayat-Khoei M, Bhattacharyya S, Katz J, Harrison D, Tauhid S, Bruso P, Houtchens MK, Edwards KR, Bakshi R. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J Neurol. 2021. https:\/\/doi.org\/10.1007\/s00415-021-10780-7.","journal-title":"J Neurol"},{"issue":"5","key":"992_CR77","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, Haddad A, Elias M, Zisman D, Naffaa ME. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines. 2021;9(5):435.","journal-title":"Vaccines"},{"key":"992_CR78","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.26452\/ijrps.v12i3.4818","volume":"12","author":"A Alshararni","year":"2021","unstructured":"Alshararni A. Acute transverse myelitis associated with COVID-19 vaccine: a case report. Int J Res Pharma Sci. 2021;12:2083\u20137.","journal-title":"Int J Res Pharma Sci"},{"key":"992_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.nerep.2021.100019","volume":"1","author":"P McLean","year":"2021","unstructured":"McLean P, Trefts L. Transverse myelitis 48 hours after the administration of an mRNA COVID 19 vaccine. Neuroimmunology Reports. 2021;1: 100019.","journal-title":"Neuroimmunology Reports"},{"key":"992_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3619131","author":"J Finsterer","year":"2021","unstructured":"Finsterer J. Exacerbating Guillain-Barr\u00e9 Syndrome Eight Days after vector-based COVID-19 vaccination. Case Rep Infect Dis. 2021. https:\/\/doi.org\/10.1155\/2021\/3619131.","journal-title":"Case Rep Infect Dis"},{"key":"992_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01143","volume":"24","author":"O Ogbebor","year":"2021","unstructured":"Ogbebor O, Seth H, Min Z, Bhanot N. Guillain-Barr\u00e9 syndrome following the first dose of SARS-CoV-2 vaccine: a temporal occurrence, not a causal association. IDCases. 2021;24: e01143.","journal-title":"IDCases"},{"key":"992_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102540","volume":"67","author":"A Razok","year":"2021","unstructured":"Razok A, Shams A, Almeer A, Zahid M. Post-COVID-19 vaccine Guillain-Barr\u00e9 syndrome; first reported case from Qatar. Ann Med Surg. 2021;67: 102540.","journal-title":"Ann Med Surg"},{"key":"992_CR83","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13426","author":"S Waheed","year":"2021","unstructured":"Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.13426.","journal-title":"Cureus"},{"key":"992_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2021.04.002","author":"GG de Terreros Caro","year":"2021","unstructured":"de Terreros Caro GG, D\u00edaz SG, Al\u00e9 MP, Gimeno MM. Bell\u2019s palsy following COVID-19 vaccination: a case report. Neurologia (Barcelona, Spain). 2021. https:\/\/doi.org\/10.1016\/j.nrleng.2021.04.002.","journal-title":"Neurologia (Barcelona, Spain)"},{"issue":"11","key":"992_CR85","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1007\/s10072-021-05496-5","volume":"42","author":"M Obermann","year":"2021","unstructured":"Obermann M, Krasniqi M, Ewers N, Fayad J, Haeberle U. Bell\u2019s palsy following COVID-19 vaccination with high CSF antibody response. Neurol Sci. 2021;42(11):4397\u20139.","journal-title":"Neurol Sci"},{"key":"992_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100217","volume":"13","author":"M Repajic","year":"2021","unstructured":"Repajic M, Lai XL, Xu P, Liu A. Bell\u2019s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell\u2019s palsy. Brain Behav Immun Health. 2021;13: 100217.","journal-title":"Brain Behav Immun Health"},{"key":"992_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106839","volume":"208","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, Janes F, Gigli GL, Curcio F, Del Negro I, D\u2019Agostini S, Fabris M, Valente M. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg. 2021;208: 106839.","journal-title":"Clin Neurol Neurosurg"},{"key":"992_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22809","author":"I Konstantinidis","year":"2021","unstructured":"Konstantinidis I, Tsakiropoulou E, H\u00e4hner A, de With K, Poulas K, Hummel T. Olfactory dysfunction after coronavirus disease 2019 (COVID-19) vaccination. Int Forum Allergy Rhinol. 2021. https:\/\/doi.org\/10.1002\/alr.22809.","journal-title":"Int Forum Allergy Rhinol"},{"key":"992_CR89","doi-asserted-by":"publisher","first-page":"103293","DOI":"10.1016\/j.amsu.2022.103293","volume":"75","author":"SH Ahmed","year":"2022","unstructured":"Ahmed SH, Waseem S, Shaikh TG, Qadir NA, Siddiqui SA, Ullah I, Waris A, Yousaf Z. SARS-CoV-2 vaccine-associated-tinnitus: a review. Ann Med Surg. 2022;75:103293.","journal-title":"Ann Med Surg"},{"issue":"5","key":"992_CR90","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jaapos.2021.05.003","volume":"25","author":"DP Reyes-Capo","year":"2021","unstructured":"Reyes-Capo DP, Stevens SM, Cavuoto KM. Acute abducens nerve palsy following COVID-19 vaccination. J Am Assoc Pediatr Ophthalmol Strabismus. 2021;25(5):302\u20133.","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"7","key":"992_CR91","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/qjmed\/hcab208","volume":"114","author":"H-H Chiu","year":"2021","unstructured":"Chiu H-H, Wei K-C, Chen A, Wang W-H. Herpes zoster following COVID-19 vaccine: a report of three cases. QJM: An Int J Med. 2021;114(7):531\u20132.","journal-title":"QJM: An Int J Med"},{"key":"992_CR92","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","volume":"12","author":"P Rodr\u00edguez-Jim\u00e9nez","year":"2021","unstructured":"Rodr\u00edguez-Jim\u00e9nez P, Chicharro P, Cabrera L-M, Segu\u00ed M, Morales-Caballero \u00c1, Llamas-Velasco M, S\u00e1nchez-P\u00e9rez J. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021;12:58\u20139.","journal-title":"JAAD Case Rep"},{"key":"992_CR93","volume":"4","author":"MR Salinas","year":"2021","unstructured":"Salinas MR, Dieppa M. Transient akathisia after the SARS-Cov-2 vaccine. Clin Park Relat Disord. 2021;4: 100098.","journal-title":"Clin Park Relat Disord"},{"issue":"4","key":"992_CR94","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.hest.2021.09.001","volume":"2","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Redzic Z. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia. Brain Hemorrhages. 2021;2(4):169\u201371.","journal-title":"Brain Hemorrhages"},{"issue":"7","key":"992_CR95","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/jth.15347","volume":"19","author":"RA Blauenfeldt","year":"2021","unstructured":"Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CCH, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost. 2021;19(7):1771\u20135.","journal-title":"J Thromb Haemost"},{"key":"992_CR96","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3841558","author":"W Fitzsimmons","year":"2021","unstructured":"Fitzsimmons W, Nance CS. Sudden onset of myelitis after COVID-19 vaccination: an under-recognized severe rare adverse event. SSRN. 2021. https:\/\/doi.org\/10.2139\/ssrn.3841558.","journal-title":"SSRN"},{"issue":"1","key":"992_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-021-10617-3","volume":"269","author":"C Martin-Villares","year":"2022","unstructured":"Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno M, de la Nogal-Fernandez B. Bell\u2019s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report. J Neurol. 2022;269(1):47\u20138.","journal-title":"J Neurol"},{"key":"992_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102803","volume":"69","author":"AF Al-Mashdali","year":"2021","unstructured":"Al-Mashdali AF, Ata YM, Sadik N. Post-COVID-19 vaccine acute hyperactive encephalopathy with dramatic response to methylprednisolone: a case report. Ann Med Surg. 2021;69: 102803.","journal-title":"Ann Med Surg"},{"key":"992_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jdcr.2021.05.042","volume":"15","author":"L Channa","year":"2021","unstructured":"Channa L, Torre K, Rothe M. Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination. JAAD Case Rep. 2021;15:60\u20131.","journal-title":"JAAD Case Rep"},{"key":"992_CR100","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16172","author":"BD Liu","year":"2021","unstructured":"Liu BD, Ugolini C, Jha P. Two cases of post-Moderna COVID-19 vaccine encephalopathy associated with nonconvulsive status epilepticus. Cureus. 2021. https:\/\/doi.org\/10.7759\/cureus.16172.","journal-title":"Cureus"},{"issue":"24","key":"992_CR101","doi-asserted-by":"publisher","first-page":"7218","DOI":"10.12998\/wjcc.v9.i24.7218","volume":"9","author":"R \u0160\u00edn","year":"2021","unstructured":"\u0160\u00edn R, \u0160truncov\u00e1 D. Status epilepticus as a complication after COVID-19 mRNA-1273 vaccine: a case report. World J Clin Cases. 2021;9(24):7218.","journal-title":"World J Clin Cases"},{"issue":"1","key":"992_CR102","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/00033197211018323","volume":"73","author":"VG Athyros","year":"2022","unstructured":"Athyros VG, Doumas M. A possible case of hypertensive crisis with intracranial haemorrhage after an mRNA anti-COVID-19 vaccine. Angiology. 2022;73(1):87\u201387.","journal-title":"Angiology"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-00992-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-00992-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-00992-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T05:04:31Z","timestamp":1677301471000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-00992-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-00992-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"18 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}